{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:00:54Z","timestamp":1775790054288,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000245","name":"michael smith foundation for health research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"name":"council of chief medical officers of health of canada"},{"DOI":"10.13039\/501100012395","name":"canadian immunization research network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.17269\/s41997-022-00648-2","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T13:03:15Z","timestamp":1653570195000},"page":"776-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Factors associated with intention to receive vaccines for bacterial sexually transmitted infections among young HPV-vaccinated Canadian women"],"prefix":"10.17269","volume":"113","author":[{"given":"Anna","family":"de Waal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Sarai","family":"Racey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robine","family":"Donken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Plotnikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy","family":"Grennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"issue":"10","key":"648_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","volume":"19","author":"S Abraham","year":"2019","unstructured":"Abraham, S., Juel, H. B., Bang, P., Cheeseman, H. M., Dohn, R. B., Cole, T., et al. (2019). Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: A first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Infectious Diseases, 19(10), 1091\u20131100. https:\/\/doi.org\/10.1016\/S1473-3099(19)30279-8","journal-title":"The Lancet Infectious Diseases"},{"key":"648_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/ijpvm.IJPVM_49_17","volume":"8","author":"Y Bird","year":"2017","unstructured":"Bird, Y., Obidiya, O., Mahmood, R., Nwankwo, C., & Moraros, J. (2017). Human papillomavirus vaccination uptake in Canada: A systematic review and meta-analysis. International Journal of Preventive Medicine, 8, 71\u201371. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_49_17","journal-title":"International Journal of Preventive Medicine"},{"key":"648_CR3","doi-asserted-by":"publisher","unstructured":"Bodie, M., Gale-Rowe, M., Alexandre, S., Auguste, U., Tomas, K., & Martin, I. (2019). Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present. Canada Communicable Disease Report, 45(2-3), 54\u201362. https:\/\/doi.org\/10.14745\/ccdr.v45i23a02","DOI":"10.14745\/ccdr.v45i23a02"},{"issue":"7","key":"648_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/08820139.2021.1897612","volume":"50","author":"R Butterfield","year":"2021","unstructured":"Butterfield, R., & Dhanani, S. (2021). The development of human papillomavirus (HPV) vaccines and current barriers to implementation. Immunological Investigations, 50(7), 821\u2013832. https:\/\/doi.org\/10.1080\/08820139.2021.1897612","journal-title":"Immunological Investigations"},{"key":"648_CR5","first-page":"45","volume":"4","author":"VL Champion","year":"2008","unstructured":"Champion, V. L., & Skinner, C. S. (2008). The health belief model. Health Behavior and Health Education: Theory, research, and practice, 4, 45\u201365.","journal-title":"Health Behavior and Health Education: Theory, research, and practice"},{"issue":"5","key":"648_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tics.2021.02.002","volume":"25","author":"C Chevallier","year":"2021","unstructured":"Chevallier, C., Hacquin, A.-S., & Mercier, H. (2021). COVID-19 vaccine hesitancy: Shortening the last mile. Trends in Cognitive Sciences, 25(5), 331\u2013333. https:\/\/doi.org\/10.1016\/j.tics.2021.02.002","journal-title":"Trends in Cognitive Sciences"},{"key":"648_CR7","unstructured":"Donken, R. (2017). Comparing trial participants evaluating 2 vs 3 doses of the HPV vaccine to the general population in British Columbia. In 31st International Papillomavirus Conference, Cape Town, South Africa."},{"key":"648_CR8","doi-asserted-by":"publisher","unstructured":"Dub\u00e9, E., Bettinger, J. A., Fisher, W. A., Naus, M., Mahmud, S. M., & Hilderman, T. (2016). Vaccine acceptance, hesitancy and refusal in Canada: Challenges and potential approaches. Canada Communicable Disease Report, 42(12), 246\u2013251. https:\/\/doi.org\/10.14745\/ccdr.v42i12a02","DOI":"10.14745\/ccdr.v42i12a02"},{"key":"648_CR9","doi-asserted-by":"publisher","unstructured":"Epstein, M., Bailey, J. A., Manhart, L. E., Hill, K. G., Hawkins, J. D., Haggerty, K. P., et al. (2014). Understanding the link between early sexual initiation and later sexually transmitted infection: Test and replication in two longitudinal studies. The Journal of Adolescent Health, 54(4), 435\u2013441.e432. https:\/\/doi.org\/10.1016\/j.jadohealth.2013.09.016","DOI":"10.1016\/j.jadohealth.2013.09.016"},{"issue":"4","key":"648_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cid\/ciw354","volume":"63","author":"SM Garland","year":"2016","unstructured":"Garland, S. M., Kjaer, S. K., Mu\u00f1oz, N., Block, S. L., Brown, D. R., DiNubile, M. J., et al. (2016). Impact and effectiveness of the quadrivalent human papillomavirus vaccine: A systematic review of 10 years of real-world experience. Clinical Infectious Diseases, 63(4), 519\u2013527. https:\/\/doi.org\/10.1093\/cid\/ciw354","journal-title":"Clinical Infectious Diseases"},{"issue":"14","key":"648_CR11","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.vaccine.2013.11.007","volume":"32","author":"GP Garnett","year":"2014","unstructured":"Garnett, G. P. (2014). The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and disease. Vaccine, 32(14), 1536\u20131542. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.007","journal-title":"Vaccine"},{"issue":"1","key":"648_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00430-014-0373-y","volume":"204","author":"WH Gerlich","year":"2015","unstructured":"Gerlich, W. H. (2015). Prophylactic vaccination against hepatitis B: Achievements, challenges and perspectives. Medical Microbiology and Immunology, 204(1), 39\u201355. https:\/\/doi.org\/10.1007\/s00430-014-0373-y","journal-title":"Medical Microbiology and Immunology"},{"key":"648_CR13","doi-asserted-by":"publisher","unstructured":"Gottlieb, S., & Johnston, C. (2017). Future prospects for new vaccines against sexually transmitted infections. Current Opinion in Infectious Diseases, 30(1), 77\u201386. https:\/\/doi.org\/10.1097\/QCO.0000000000000343","DOI":"10.1097\/QCO.0000000000000343"},{"issue":"26","key":"648_CR14","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.vaccine.2016.03.111","volume":"34","author":"S Gottlieb","year":"2016","unstructured":"Gottlieb, S., Deal, C. D., Giersing, B., Rees, H., Bolan, G., Johnston, C., et al. (2016). The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps. Vaccine, 34(26), 2939\u20132947. https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.111","journal-title":"Vaccine"},{"issue":"14","key":"648_CR15","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.vaccine.2013.07.087","volume":"32","author":"S Gottlieb","year":"2014","unstructured":"Gottlieb, S., Low, N., Newman, L. M., Bolan, G., Kamb, M., & Broutet, N. (2014). Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines. Vaccine, 32(14), 1527\u20131535. https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.087","journal-title":"Vaccine"},{"key":"648_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/ijpvm.IJPVM_444_17","volume":"9","author":"E Haghir","year":"2018","unstructured":"Haghir, E., Madampage, C., Mahmood, R., & Moraros, J. (2018). Risk factors associated with self-reported sexually transmitted infections among postsecondary students in Canada. International Journal of Preventive Medicine, 9, 49\u201349. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_444_17","journal-title":"International Journal of Preventive Medicine"},{"issue":"1","key":"648_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/fmb.14.110","volume":"10","author":"G Hughes","year":"2015","unstructured":"Hughes, G., & Field, N. (2015). The epidemiology of sexually transmitted infections in the UK: Impact of behavior, services and interventions. Future Microbiology, 10(1), 35\u201351.","journal-title":"Future Microbiology"},{"issue":"6","key":"648_CR18","doi-asserted-by":"publisher","first-page":"e20624","DOI":"10.1371\/journal.pone.0020624","volume":"6","author":"A Leval","year":"2011","unstructured":"Leval, A., Sundstr\u00f6m, K., Ploner, A., Dahlstr\u00f6m, L. A., Widmark, C., & Spar\u00e9n, P. (2011). Assessing perceived risk and STI prevention behavior: A national population-based study with special reference to HPV. PLoS ONE, 6(6), e20624\u2013e20624. https:\/\/doi.org\/10.1371\/journal.pone.0020624","journal-title":"PLoS ONE"},{"issue":"5","key":"648_CR19","doi-asserted-by":"publisher","first-page":"e1000270","DOI":"10.1371\/journal.pmed.1000270","volume":"7","author":"G Ogilvie","year":"2010","unstructured":"Ogilvie, G., Anderson, M., Marra, F., McNeil, S., Pielak, K., Dawar, M., et al. (2010). A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: Parental factors associated with HPV vaccine receipt. PLoS Medicine, 7(5), e1000270\u2013e1000270. https:\/\/doi.org\/10.1371\/journal.pmed.1000270","journal-title":"PLoS Medicine"},{"issue":"12","key":"648_CR20","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1503\/cmaj.071022","volume":"177","author":"G Ogilvie","year":"2007","unstructured":"Ogilvie, G., Remple, V. P., Marra, F., McNeil, S. A., Naus, M., Pielak, K. L., et al. (2007). Parental intention to have daughters receive the human papillomavirus vaccine. Canadian Medical Association Journal, 177(12), 1506. https:\/\/doi.org\/10.1503\/cmaj.071022","journal-title":"Canadian Medical Association Journal"},{"key":"648_CR21","doi-asserted-by":"publisher","unstructured":"Patridge, E. F., & Bardyn, T. P. (2018). Research Electronic Data Capture (REDCap). Journal of the Medical Library Association, 106(1), 142\u2013144. https:\/\/doi.org\/10.5195\/jmla.2018.319","DOI":"10.5195\/jmla.2018.319"},{"key":"648_CR22","first-page":"334.333","volume-title":"Update on sexually transmitted infections in Canada, 2016","author":"PHAC","year":"2019","unstructured":"PHAC. (2019). Update on sexually transmitted infections in Canada, 2016 (Vol. 261, p. 334.333). Public Health Agency of Canada."},{"key":"648_CR23","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.jvacx.2021.100107","volume":"8","author":"KM Plotnikoff","year":"2021","unstructured":"Plotnikoff, K. M., Donken, R., Smith, L., Cameron, C., LaMontagne, D. S., Bettinger, J. A., et al. (2021). Priorities for sexually transmitted infection vaccine research and development: Results from a survey of global leaders and representatives. Vaccine: X, 8, 100107. https:\/\/doi.org\/10.1016\/j.jvacx.2021.100107","journal-title":"Vaccine: X"},{"key":"648_CR24","doi-asserted-by":"publisher","unstructured":"Plotnikoff, K. M., Ogilvie, G. S., Smith, L., Donken, R., Pedersen, H. N., Samji, H., et al. (2020). Factors associated with interest in bacterial sexually transmitted infection vaccines at two large sexually transmitted infection clinics in British Columbia, Canada. Sexually Transmitted Infections, sextrans-2019-054311. https:\/\/doi.org\/10.1136\/sextrans-2019-054311","DOI":"10.1136\/sextrans-2019-054311"},{"issue":"1","key":"648_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/MOP.0000000000000578","volume":"30","author":"CL Shannon","year":"2018","unstructured":"Shannon, C. L., & Klausner, J. D. (2018). The growing epidemic of sexually transmitted infections in adolescents: A neglected population. Current Opinion in Pediatrics, 30(1), 137\u2013143. https:\/\/doi.org\/10.1097\/MOP.0000000000000578","journal-title":"Current Opinion in Pediatrics"},{"issue":"4","key":"648_CR26","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/S2468-2667(20)30010-4","volume":"5","author":"KT Simms","year":"2020","unstructured":"Simms, K. T., Hanley, S. J. B., Smith, M. A., Keane, A., & Canfell, K. (2020). Impact of HPV vaccine hesitancy on cervical cancer in Japan: A modelling study. The Lancet Public Health, 5(4), e223\u2013e234. https:\/\/doi.org\/10.1016\/S2468-2667(20)30010-4","journal-title":"The Lancet Public Health"},{"issue":"8","key":"648_CR27","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/s41591-021-01454-y","volume":"27","author":"JS Sol\u00eds Arce","year":"2021","unstructured":"Sol\u00eds Arce, J. S., Warren, S. S., Meriggi, N. F., Scacco, A., McMurry, N., Voors, M., et al. (2021). COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nature Medicine, 27(8), 1385\u20131394. https:\/\/doi.org\/10.1038\/s41591-021-01454-y","journal-title":"Nature Medicine"},{"issue":"1","key":"648_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajog.2016.08.008","volume":"216","author":"DG Tsevat","year":"2017","unstructured":"Tsevat, D. G., Wiesenfeld, H. C., Parks, C., & Peipert, J. F. (2017). Sexually transmitted diseases and infertility. American Journal of Obstetrics and Gynecology, 216(1), 1\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2016.08.008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"648_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/OLQ.0b013e31824717ae","volume":"39","author":"AR Tuite","year":"2012","unstructured":"Tuite, A. R., Jayaraman, G. C., Allen, V. G., & Fisman, D. N. (2012). Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada. Sexually Transmitted Diseases, 39(4), 260\u2013267. https:\/\/doi.org\/10.1097\/OLQ.0b013e31824717ae","journal-title":"Sexually Transmitted Diseases"},{"key":"648_CR30","unstructured":"WHO. (2019). Ten threats to global health in 2019, World Health Organization. World Health Organization. Accessed 20 January 2022."}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-022-00648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.17269\/s41997-022-00648-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-022-00648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:39:45Z","timestamp":1744202385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.17269\/s41997-022-00648-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.17269\/s41997-022-00648-2","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"5 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the UBC Children\u2019s and Women\u2019s Research Ethics Board (H12-01246).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}